Hulio Interchangeability to Humira®, Comparing Pharmacokinetics, Efficacy, Safety and Immunogenicity
Phase 3
Completed
- Conditions
- Moderate Chronic Plaque PsoriasisSevere Chronic Plaque Psoriasis
- Interventions
- First Posted Date
- 2022-12-05
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Biocon Biologics Inc.
- Target Recruit Count
- 374
- Registration Number
- NCT05637515
- Locations
- 🇪🇪
Site 203 - North Estonia Medical Centre Foundation, Talinn, Estonia
🇪🇪Site 205 - OÜ Innomedica, Tartu, Estonia
🇵🇱Site 105 - Twoja Przychodnia-Szczecinskie Centrum Medyczne, Szczecin, Poland
© Copyright 2025. All Rights Reserved by MedPath